Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.83
-$0.03-3.49%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.40M | 27.33M | 17.83M | 23.31M | 18.20M |
| Total Depreciation and Amortization | 5.16M | 5.01M | 5.18M | 5.12M | 4.72M |
| Total Amortization of Deferred Charges | -- | -- | 1.03M | -- | -- |
| Total Other Non-Cash Items | 20.16M | 13.09M | 17.99M | 2.89M | 14.74M |
| Change in Net Operating Assets | -24.83M | -58.10M | 26.59M | -7.67M | -11.53M |
| Cash from Operations | 21.89M | -12.66M | 68.61M | 23.65M | 26.13M |
| Capital Expenditure | -6.87M | -6.37M | -12.28M | -7.02M | -4.44M |
| Sale of Property, Plant, and Equipment | 2.96M | 55.00K | 422.60K | 6.40K | 151.00K |
| Cash Acquisitions | -2.98M | -228.80K | -7.88M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.91M | 4.06M | -2.45M | -2.28M | -1.02M |
| Cash from Investing | 2.02M | -2.48M | -22.19M | -9.29M | -5.30M |
| Total Debt Issued | 629.52M | 1.19B | 631.91M | 1.15B | 2.40B |
| Total Debt Repaid | -931.11M | -703.66M | -439.99M | -999.49M | -2.10B |
| Issuance of Common Stock | -- | -- | 1.83B | -- | 36.08M |
| Repurchase of Common Stock | -4.69M | -26.57M | -1.83B | -28.76M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.14M | -10.79M | -10.67M | -21.00M | 0.00 |
| Other Financing Activities | -171.56M | -171.23M | -188.48M | -186.45M | -191.58M |
| Cash from Financing | -38.45M | 4.92M | -10.50M | -24.51M | 7.21M |
| Foreign Exchange rate Adjustments | 2.03M | -2.39M | -3.44M | -3.31M | -6.05M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.50M | -12.61M | 32.49M | -13.45M | 21.99M |